Henry K Tsai

Summary

Affiliation: Harvard University
Country: USA

Publications

  1. ncbi request reprint Androgen deprivation therapy for localized prostate cancer and the risk of cardiovascular mortality
    Henry K Tsai
    Harvard Radiation Oncology Program, Harvard Medical School, Boston, MA 02215, USA
    J Natl Cancer Inst 99:1516-24. 2007
  2. ncbi request reprint Cancer-specific mortality after radiation therapy with short-course hormonal therapy or radical prostatectomy in men with localized, intermediate-risk to high-risk prostate cancer
    Henry K Tsai
    Harvard Radiation Oncology Program, Harvard Medical School, Boston, Massachusetts, USA
    Cancer 107:2597-603. 2006
  3. ncbi request reprint Patient-reported acute gastrointestinal toxicity in men receiving 3-dimensional conformal radiation therapy for prostate cancer with or without neoadjuvant androgen suppression therapy
    Henry K Tsai
    Department of Radiation Oncology, Dana Farber Cancer Institute and Brigham and Women s Hospital, Boston, MA 02115, USA
    Urol Oncol 23:230-7. 2005
  4. doi request reprint Dose-painted intensity-modulated radiation therapy for anal cancer: a multi-institutional report of acute toxicity and response to therapy
    Lisa A Kachnic
    Department of Radiation Oncology, Boston Medical Center, Boston, MA 02118, USA
    Int J Radiat Oncol Biol Phys 82:153-8. 2012
  5. ncbi request reprint Nodular lymphocyte-predominant hodgkin lymphoma
    Henry K Tsai
    Department of Radiation Oncology, Brigham and Women s Hospital and Dana Farber Cancer Institute, Harvard Medical School, Boston, MA 02115
    Semin Radiat Oncol 17:184-9. 2007
  6. doi request reprint Long-term clinical outcomes following treatment of childhood craniopharyngioma
    Karen M Winkfield
    Harvard Radiation Oncology Program, Harvard Medical School, Boston, Massachusetts, USA
    Pediatr Blood Cancer 56:1120-6. 2011

Collaborators

Detail Information

Publications6

  1. ncbi request reprint Androgen deprivation therapy for localized prostate cancer and the risk of cardiovascular mortality
    Henry K Tsai
    Harvard Radiation Oncology Program, Harvard Medical School, Boston, MA 02215, USA
    J Natl Cancer Inst 99:1516-24. 2007
    ..We investigated whether androgen deprivation therapy (ADT) use is associated with an increased risk of death from cardiovascular causes in patients treated for localized prostate cancer...
  2. ncbi request reprint Cancer-specific mortality after radiation therapy with short-course hormonal therapy or radical prostatectomy in men with localized, intermediate-risk to high-risk prostate cancer
    Henry K Tsai
    Harvard Radiation Oncology Program, Harvard Medical School, Boston, Massachusetts, USA
    Cancer 107:2597-603. 2006
    ..The authors estimated PCSM after radiation therapy with short-course androgen suppression therapy (RT+AST) or radical prostatectomy (RP) in men with clinically localized, intermediate-risk to high-risk prostate cancer...
  3. ncbi request reprint Patient-reported acute gastrointestinal toxicity in men receiving 3-dimensional conformal radiation therapy for prostate cancer with or without neoadjuvant androgen suppression therapy
    Henry K Tsai
    Department of Radiation Oncology, Dana Farber Cancer Institute and Brigham and Women s Hospital, Boston, MA 02115, USA
    Urol Oncol 23:230-7. 2005
    ..To investigate the impact of 2 months of neoadjuvant and 2 months of concurrent hormonal therapy on the acute gastrointestinal (GI) toxicities associated with 3-dimensional conformal radiation therapy (3D-CRT) for prostate adenocarcinoma...
  4. doi request reprint Dose-painted intensity-modulated radiation therapy for anal cancer: a multi-institutional report of acute toxicity and response to therapy
    Lisa A Kachnic
    Department of Radiation Oncology, Boston Medical Center, Boston, MA 02118, USA
    Int J Radiat Oncol Biol Phys 82:153-8. 2012
    ..Chemoradiation for anal cancer yields effective tumor control, but is associated with significant acute toxicity. We report our multi-institutional experience using dose-painted IMRT (DP-IMRT)...
  5. ncbi request reprint Nodular lymphocyte-predominant hodgkin lymphoma
    Henry K Tsai
    Department of Radiation Oncology, Brigham and Women s Hospital and Dana Farber Cancer Institute, Harvard Medical School, Boston, MA 02115
    Semin Radiat Oncol 17:184-9. 2007
    ..Treatment-related late effects contribute significantly to the causes of death in patients treated for NLPHL...
  6. doi request reprint Long-term clinical outcomes following treatment of childhood craniopharyngioma
    Karen M Winkfield
    Harvard Radiation Oncology Program, Harvard Medical School, Boston, Massachusetts, USA
    Pediatr Blood Cancer 56:1120-6. 2011
    ....